Overcoming amantadine resistance
نویسندگان
چکیده
منابع مشابه
Overcoming antiangiogenic resistance.
The success of drugs targeting angiogenesis is tempered by the transient duration of disease control and modest survival improvement. The very hypoxic stress produced by successful therapy may lead to upregulation of multiple pathways that promote angiogenesis and invasive behavior. Overcoming this evasive resistance may further improve outcome.
متن کاملUnderstanding and overcoming antibiotic resistance
Antibiotic drugs have revolutionized medicine and made our modern way of life possible. In addition to their essential role in the clinic, antibiotics are used in a huge array of non-medical applications, from promoting growth in livestock, to preserving building materials from contamination, to treating blight in orchards. However, overuse threatens their efficacy due to the promotion and spre...
متن کاملOvercoming multidrug resistance with nanomedicines.
INTRODUCTION Cancer remains the leading cause of death worldwide. Numerous therapeutic strategies that include smart biological treatments toward specific cellular pathways are being developed. Yet, inherent and acquired multidrug resistance (MDR) to chemotherapeutic drugs remains the major obstacle in effective cancer treatments. AREAS COVERED Herein, we focused on an implementation of nanos...
متن کاملValerie Weaver: Overcoming cancer's stiff resistance
E ach year in the United States alone, more than 200,000 cases of breast cancer are diagnosed. Most women fi nd their tumors on their own, by feeling a lump in their breast. Tumors can be detected in this way because they are stiffer than normal tissue, explains Valerie Weaver, Director of UCSF's Center for Bioengineering and Tissue Regeneration. This stiffness is both a consequence and a cause...
متن کاملOvercoming chemotherapy resistance in prostate cancer.
Although treatment for prostate cancer has improved over the past several years, taxanes remain the only form of chemotherapy that improves survival in patients with metastatic castration-resistant prostate cancer (mCRPC). In addition to the promising therapeutic cancer vaccines and newly developed agents targeting androgen receptor signaling, chemotherapy-based treatments will likely continue ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Science-Business eXchange
سال: 2013
ISSN: 1945-3477
DOI: 10.1038/scibx.2013.27